5-Amino-1MQ
Small-molecule NNMT inhibitor (not a peptide). Blocks nicotinamide N-methyltransferase to preserve cellular methyl-donor pools and NAD+.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
Tracked alongside peptides in biohacker stacks. Preclinical models show reduced adipose hypertrophy and improved muscle stem-cell function. No human RCTs published. Different chemistry from peptides — included here because it shows up in the same protocols.
Not a peptide; included for stack context. Zero published human trials. Long-term safety unknown.
Per-claim grading. Each claim is graded independently — same peptide, different claims can carry different grades.
- DMechanistic / anecdotal
5-Amino-1MQ — primary mechanism: small-molecule nnmt inhibitor (not a peptide). blocks nicotinamide n-methyltransferase to preserve cellular methyl-donor pools and nad+.
1 supporting referencesVerified 5d ago
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Research compound